The original report describes mutations in βI-, βIIA-, or βIVB-tubulin genes that make these tubulins more like the βIII-tubulin isotype which is overexpressed in aggressive and metastatic cancers [118]. This evidence concerns the gene CACNA1A and metastatic malignant neoplasm.